摘要:
Eine niedermolekulare Huminatfraktion wird gewonnen, indem zu einer wäßrigen Suspension huminstoffhaltiger Produkte unter Rühren eine alkalisch wirkende Substanz so zudosiert wird, daß der pH-Wert 7 nicht überschritten wird, die Suspension bis zur Konstanz des pH-Wertes weitergerührt wird, danach sedimentiert und die weitgehend feststofffreie Lösung abgetrennt und danach zentrifugiert wird und die dabei erhaltene geklärte Lösung einer Ultrafiltration unterworfen wird.
摘要:
Methods of treating fluid retention disorders with the B isomers of guanylin family peptides are described herein. UgnB, when compared to the A isomer (UgnA), exhibits a conventional sigmoidal dose-response relationship in its natriuetic activity. Further, unlike UgnA, UgnB only weakly activates the GC-C receptor. Compositions comprising purified, or mixtures containing B isomers of guanylin family peptides are described herein are therefore useful for the treatment of fluid retention disorders.
摘要:
The present invention relates to a pharmaceutical or veterinary or nutritional or personal care composition comprising coenzyme Q10 (CoQI0), reduced CoQ1O, or mixtures thereof and oxygenated dibenzo-α-pyrone or an amino acyl ester thereof. The composition of the present invention is able to support and/or provide therapy to individuals at risk and/or under treatment for dysfunctions of energy metabolism, and specifically, for mitochondrial diseases.
摘要:
A pharmaceutical composition comprising an oxihumic acid, salt, ester or derivative thereof as an active ingredient is disclosed. The composition is preferably administered orally for stimulating lymphocytes in a human, animal or bird. It may be used in treating viral and bacterial infections, HIV infections, opportunistic diseases, inflammation, pain and fever, cancer growth and diseases associated with viral infection and a depressed immune system.
摘要:
The present invention discloses the use of natural, commercially available Humic Acid preparations in the treatment of human immunodeficiency virus (HIV) through its demonstrated anti-HIV-1 effect, anti-syncytia formation effect and/or immunostimulation of IL-2. The Humic Acid preparations hereof are thus useful in the treatment of HIV and AIDS and are described as particularly useful alone or as adjuvants to be co-administered in immunovaccinations against HIV.